Home › Therapeutic areas › Oncology › Acute Myeloid Leukemia
Acute Myeloid Leukemia (13 companies)
Companies with an active program in Acute Myeloid Leukemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics | Oncology | 1 | Phase 2 | 6 |
| ALLO | Allogene Therapeutics | ImmunologyOncology Rare | 1 | Phase 2 | 10 |
| APVO | Aptevo Therapeutics | Oncology | 1 | Phase 1 | 8 |
| BMEA | Biomea Fusion | MetabolicOncology | 1 | Phase 2 | 4 |
| CGEM | Cullinan Therapeutics | HematologyImmunology+2 Rare | 1 | NDA Submitted | 10 |
| GERN | Geron | Oncology | 1 | Approved | 3 |
| INAB | IN8bio | ImmunologyOncology | 1 | Phase 2 | 6 |
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | 12 |
| MRKR | Marker Therapeutics | Oncology | 1 | Phase 1 | 4 |
| MBRX | Moleculin Biotech | Oncology | 3 | Phase 2 | 10 |
| OMER | Omeros | HematologyNeurology+2 Rare | 1 | Approved | 6 |
| SLS | SELLAS Life Sciences Group | Oncology | 2 | Phase 3 | 9 |
| SNDX | Syndax Pharmaceuticals | ImmunologyOncology+1 Rare | 1 | Approved | 8 |
No companies match.